Treatment is getting easier in our days, with medication provided – at least in Europe and the USA which has less side effects and minimize the pill burden.Two new HIV drugs in development that show promise for less frequent dosing were previewed at a conference in San Francisco recently. Albuvirtide is the drug called which could one day suppress HIV for a week while S/GSK1265744 might even do this for a month. First studies show promising results. For more info read a report about the new research here.
Related articles
- Effective HIV care benefited all HIV patients, regardless of demographics and behavioral risk (eurekalert.org)
- HIV Treatable: Single Dose Regiment Is Finally In The Market (seeclouds.com)
- Poor HIV patients improve with care beyond drugs: study (news.yahoo.com)
- Immune system’s door unlocked: Science finds out why specific cells let HIV in (EndtheLie.com)
Filed under: HIV and AIDS, HIV Treatment, Medical and Research, Networking, Aids, albuvirtide, china, drug, Food and Drug Administration, hiv, HIV treatment, ICAAC, once-monthly, once-weekly, people living with the virus, research, S/GSK1265744, San Francisco, south africa
God, AIDS, Africa & HOPE 